EP1206940A1 - Use of tea for treating and/or preventing infections caused by methicillin-resistant staphylococcus aureus - Google Patents

Use of tea for treating and/or preventing infections caused by methicillin-resistant staphylococcus aureus

Info

Publication number
EP1206940A1
EP1206940A1 EP01126544.4A EP01126544A EP1206940A1 EP 1206940 A1 EP1206940 A1 EP 1206940A1 EP 01126544 A EP01126544 A EP 01126544A EP 1206940 A1 EP1206940 A1 EP 1206940A1
Authority
EP
European Patent Office
Prior art keywords
methicillin
tea
treating
staphylococcus aureus
infections caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01126544.4A
Other languages
German (de)
French (fr)
Inventor
Hiroshi Fujiwara
Ken Toyo Seiyaku Kabushiki Kaisha Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Seiyaku Kasei Co Ltd
Original Assignee
Toyo Seiyaku Kasei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Seiyaku Kasei Co Ltd filed Critical Toyo Seiyaku Kasei Co Ltd
Publication of EP1206940A1 publication Critical patent/EP1206940A1/en
Withdrawn legal-status Critical Current

Links

EP01126544.4A 2000-11-15 2001-11-14 Use of tea for treating and/or preventing infections caused by methicillin-resistant staphylococcus aureus Withdrawn EP1206940A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000348728 2000-11-15

Publications (1)

Publication Number Publication Date
EP1206940A1 true EP1206940A1 (en) 2002-05-22

Family

ID=

Similar Documents

Publication Publication Date Title
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
WO2001051456A3 (en) Antibacterial agents
AU2001286878A1 (en) Oxazolidinones and their use as antibacterial agents
GB0125222D0 (en) Composition for the treatment of microbial infections
ZA200202306B (en) Topical treatment of streptococcal infections.
SI1427711T1 (en) Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
ZA200205113B (en) Novel lipopeptides as antibacterial agents.
WO2002007742A3 (en) Bacteriophage having multiple host range
ZA200205106B (en) Novel lipopeptides as antibacterial agents.
ZA200507070B (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
EP1594444A3 (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
GB0107661D0 (en) Staphylococcus aureus
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2001239774A1 (en) Antibacterial agents and compositions, methods and systems employing same
EP1037650A4 (en) Methods and compositions for the treatment and prevention of staphylococcus aureus infections
AU2002232558A1 (en) Compounds, compositions and methods for treatment of parasitic infections
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2247701A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
AU1572101A (en) Admixture of linezolid and other antibacterial agents
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
AU1212501A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
AU2001237025A1 (en) Antimicrobial composition and articles
AU2263801A (en) Quinolone compounds for use in treating viral infections
EP1206940A1 (en) Use of tea for treating and/or preventing infections caused by methicillin-resistant staphylococcus aureus